Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04139187
Other study ID # 96793518.3.0000.5323
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date September 15, 2019
Est. completion date December 2020

Study information

Verified date June 2020
Source Universidade Federal de Santa Maria
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Anterior cruciate ligament (ACL) is the most frequently injured knee ligament during performance of recreational activities and sports. In the United States, the annual incidence is 68.6 per 100,000 people per year and in Brazil, the estimation of ACL reconstruction increases 64%. There are different biomechanical profiles of risk factors for an ACL injury variable, the ligament dominance, the quadriceps dominance, the trunk dominance, and the leg dominance. Thus, the purpose of this study is to investigate the biomechanics adaptations after power and strength combined training protocol in healthy individuals. A second aim is to determine the effect of the training on knee injury risk factors.


Description:

This is a parallel randomized clinical trial comparing the effect of combined training with power and strength exercises on lower extremity biomechanics in healthy individuals.

The sample size was calculated with G*Power software using the ANOVA: Repeated measures, within-between interaction, 90% power, alpha 0.05, and 30% drop-out. Data from the tuck jump test (knee flexion range) by Makaruk (2014) were considered for this calculation with effect size 0.46. Thus, a total of 32 individuals (16 per group) is required for this study. To ensure the proper simple size, after collecting the first five participants per group, the sample size will be checked again.

The participants will be randomized in experimental and no intervention groups inside each risk profile group. Randomization ratio will be 1:1 and interventions will last 10 weeks, with two weekly sessions for the exercise arms.

The outcomes will include functional clinical tests, kinematic and kinetic variables during landing tasks, and strength of knee and hip muscles.

The data analysis will be performed by intention to treat and per protocol. Generalized estimating equations will be used to identify interaction effects of groups and time followed by Bonferroni post-hoc. When effect are found, effect size will be estimated. Missing data will be estimate by statistical analysis.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 32
Est. completion date December 2020
Est. primary completion date December 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria:

- Male sex;

- Age between 18 and 30 years old;

- Who practice physical activity (except: strength and jump training) between 80 and 150 minute per week;

- No previous muscle lower extremity injury at least 6 months prior to recruitment;

- No previous ligament and tendon lower extremity injury or surgery;

- No auditory, vestibular, visual or musculoskeletal injuries or disease that impairment the execution of assessments or training protocol;

- No hypertension, cardiovascular or respiratory disease.

Exclusion Criteria:

- Body mass index greater than 35 kg/m².

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Combined training with power and strength exercises
The training will be compose by power and strength exercises and divided in two days. One day with the exercises: vertical jumps, box jumps, sit-ups, back-extension and guided squat. The second with half squat jumps, high straight jumps, bounding jumps, drop jumps and sprint. Both days will be started with warm up on treadmill running lasting 5 minutes at 6.5-7.5 km/h. The training protocol includes 20 sessions with 2 sessions per week during 10 weeks (2 weeks to adaptation and others 8 to training with progression of load after 4 weeks).

Locations

Country Name City State
Brazil Karine Josibel Velasques Stoelben Uruguaiana Rio Grande Do Sul

Sponsors (3)

Lead Sponsor Collaborator
Universidade Federal de Santa Maria Conselho Nacional de Desenvolvimento Científico e Tecnológico, Universidade Federal do Pampa

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Other Training load of each training session Product between rate of perceived exertion and session duration training At the end of each training session throughout 10 weeks
Other Muscle Soreness after each training session Value from visual analog scale (score between 0 to 10 points) representative to discomfort or pain after training sessions. Higher values represent worst discomfor/pain 24 and 48 hours after each training session throughout 10 weeks
Primary Change from baseline peak sagittal plane angle of ankle, knee and hip from both legs Peak angle of sagittal plane during landing task Baseline and up to 10 weeks
Primary Change from baseline value of sagittal plane angles for ankle, knee, hip, pelvis from both legs, and trunk Value at initial contact instant and maximal knee flexion instant of landing task Baseline and up to 10 weeks
Primary Change from baseline value of frontal plane angles for ankle, knee, hip, pelvis from both legs, and trunk Value at initial contact instant and maximal knee flexion instant of landing task Baseline and up to 10 weeks
Primary Change from baseline value of transverse plane angles for hip, pelvis from both legs, and trunk Value at initial contact instant and maximal knee flexion instant of landing task Baseline and up to 10 weeks
Primary Change from baseline peak frontal plane angle of knee and hip from both legs Peak angle of frontal plane during landing task Baseline and up to 10 weeks
Primary Change from baseline range of knee frontal plane angle from both legs Range of frontal plane angle between initial contact instant and maximal knee flexion instant of landing task Baseline and up to 10 weeks
Primary Change from baseline range of knee sagittal plane angle from both legs Range of sagittal plane angle between initial contact instant and maximal knee flexion instant of landing task Baseline and up to 10 weeks
Primary Change from baseline value of sagittal plane joint moment knee and hip from both legs Value at initial contact instant and maximal knee flexion instant of landing task Baseline and up to 10 weeks
Primary Change from baseline value of frontal plane joint moment knee and hip from both legs Value at initial contact instant and maximal knee flexion instant of landing task Baseline and up to 10 weeks
Primary Change from baseline peak of knee frontal plane joint moment from both legs Peak of joint moment during landing task Baseline and up to 10 weeks
Primary Change from baseline value of ground reaction force vertical component from both legs Value at maximal knee flexion instant of landing task Baseline and up to 10 weeks
Primary Change from baseline value of loading rate from both legs Value calculated by relation between peak of ground reaction force vertical component and time to peak from initial contact during landing task Baseline and up to 10 weeks
Primary Change from baseline peak of ground reaction force vertical component from both legs Peak of ground reaction force during landing task Baseline and up to 10 weeks
Primary Change from baseline value of muscle maximal isometric strength for knee extensors and flexors, and hip aductors and abductors from both legs Value of maximal isometric strength Baseline and up to 10 weeks
Secondary Change from baseline pennation angle of muscle fibers of knee extensors and flexors from both legs The angle between the longitudinal axis of the entire muscle and its fibers. Baseline and up to 10 weeks
Secondary Change from baseline muscle fascicle length of knee extensors and flexors from both legs The distance between the intersection composed of the superficial aponeurosis and fascicle and the intersection composed of the deep aponeurosis and the fascicle Baseline and up to 10 weeks
Secondary Change from baseline muscle thickness of knee extensors and flexors from both legs Estimation of muscle cross-sectional area Baseline and up to 10 weeks
Secondary Change from baseline power value of ankle, knee and hip joints from both legs Relation of work and velocity during landing task Baseline and up to 10 weeks
Secondary Change from baseline dynamic strength of lower extremities muscles The force developed to perform one maximal repetition to perform leg press and squat tasks Baseline and up to 10 weeks
Secondary Change from baseline maximal dorsiflexion amplitude of ankle joint from both legs Maximal dorsiflexion amplitude obtained during lunge test Baseline and up to 10 weeks
Secondary Change from baseline dynamic balance of lower extremities from both legs Dynamic balance is assessed according the displacement obtained during Star Excursion Balance Test Baseline and up to 10 weeks
Secondary Change from baseline dynamic balance index of asymmetry between legs Dynamic balance is assessed according the displacement obtained during Star Excursion Balance Test. The asymmetry index is calculated by relation between preferred and non preferred legs. Baseline and up to 10 weeks
Secondary Change from baseline quality of dynamic movement of lower extremities from both legs Quality of movement is assessed according the escore obtained during Lateral Step Down test performance Baseline and up to 10 weeks
Secondary Change from baseline asymmetry index of quality of dynamic movement between legs Quality of movement is assessed according the escore obtained during Lateral Step Down test performance. The asymmetry index is calculated by relation between preferred and non preferred legs. Baseline and up to 10 weeks
Secondary Change from baseline functional physical performance of lower extremities from both legs Assessed according the maximal distance obtained during hop tests performance (single, triple and crossover) Baseline and up to 10 weeks
Secondary Change from baseline asymmetry index of functional physical performance between legs Assessed according the maximal distance obtained during hop tests performance (single, triple and crossover). The asymmetry index is calculated by relation between preferred and non preferred legs. Baseline and up to 10 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1